Lisbet Westergaard

NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs

Ulla Ribel, Marianne O. Larsen, Bidda Rolin et al. · European Journal of Pharmacology · 2002 · 78 citations

Medicine, Endocrinology, Pharmacology +12

Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial*

Thomas Danne, Nicolin Datz, Lars Endahl et al. · Pediatric Diabetes · 2008 · 58 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes

Fiona Smeeton, F. Shojaee Moradie, R. H. Jones et al. · Diabetologia · 2009 · 33 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus

Lisbet Westergaard, Lene Alifrangis, Stephen T. Buckley et al. · Clinical Drug Investigation · 2024 · 13 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12